Achieving a global standard of health requires creating new pharmaceutical tools says Professor Kishor Wasan Global Orphan Diseases Under-Medicated and Over-Medicalized, Professor Kishor Wasan Said SASKATOON, SK, CANADA, October 13, 2021 /EINPresswire.com/ — If you live in Canada, the United … Read More

AUSTIN, Texas, Oct. 8, 2021 /PRNewswire/ — Austin’s Big Race Weekend shifts into high gear with the launch of Club SI, an upscale and unforgettable experience. Club SI at COTA will feature appearances from celebrity guests and tastemakers, an upscale party atmosphere, … Read More

PRNewswire Article CALGARY, AB. and BATON ROUGE, La., Sept. 21, 2021 /PRNewswire/ — At a time when global health and dietary challenges require rapid cutting-edge technologies and innovation to improve well-being, Skymount Medical, using research developed at Louisiana State University (LSU), announces the launch of … Read More

Medium.com Authority Magazine Article   To that end, be open to and seek to learn more about all different kinds of disciplines, so the technology has as many building blocks as possible to build an effective solution. DeepDrug draws on … Read More

HealthcareGlobal.com Article The COVID-19 pandemic was declared almost 18 months ago. In that time the scientific community has rallied to produce a variety of tests and several effective vaccines along with a number of other innovations. Here we take a look … Read More

PR Newswire Article CALGARY, AB. and BATON ROUGE, La., Aug. 11, 2021 /PRNewswire/ — Skymount Medical, a drug discovery company, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies, known as SM-19, for COVID-19 patients. In vitro (cell) and in … Read More

NewsFileCorp Article Vancouver, British Columbia–(Newsfile Corp. – December 31, 2020) – iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”), iCo Therapeutics, Inc. (“iCo”) and Skymount Medical, Inc. (“Skymount”) announced today that they have entered into a non-binding Memorandum … Read More

ISU EDU Article Artificial intelligence software developed by an interdisciplinary team of LSU researchers could shorten the time for drug development from 15 years to 15 days; save lives, reduce symptoms. BATON ROUGE, June 5, 2020 — A Calgary-based technology company, Skymount … Read More